Home > Category > Signaling Pathways > Metabolism > PCSK9 > Alirocumab

阿利库单抗;阿莫罗布单抗; 阿利西尤单抗

ChemLeader 95+%
Catalog No:CLA1014 CAS No.:1245916-14-6 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days ¥3000.00 Visible after login
- +
5 mg 3-5days ¥12500.00 Visible after login
- +
10 mg 3-5days ¥20000.00 Visible after login
- +
50 mg 3-5days ¥80000.00 Visible after login
- +
100 mg 3-5days ¥125000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Alirocumab
CAS1245916-14-6
AppearanceA liquid
Storage condition Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles
Product details

Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation. Alirocumab (REGN 727) is a human monoclonal antibody inhibitor of PCSK9. Alirocumab is a monoclonal antibody. Alirocumab has anti-inflammatory, antiangiogenic and antioxidant effects. Alirocumab can be used in the study of hypercholesterolemia.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays